Similar articles

• [Beta blockaders in the treatment of hypertension. Part 2. Antihypertensive effect: hypotheses on the mechanism of action and practical methods of treatment].

  Andrejak M, Fournier A, Hardin JM, Lambrey G, de Frémont JF, Coevoet B. Andrejak M, et al. Coeur Med Interne. 1978 Jul-Sep;17(3):381-400. Coeur Med Interne. 1978. PMID: 31260 Review. French. No abstract available.
• [Beta-blockaders in hypertension].

  Erikssen J, Storm-Mathisen H. Erikssen J, et al. Tidsskr Nor Laegeforen. 1973 Sep 10;93(25):1780-4. Tidsskr Nor Laegeforen. 1973. PMID: 4149223 Norwegian. No abstract available.
• Pharmacological basis for combination therapy of hypertension.

  Dolley CT. Dolley CT. Annu Rev Pharmacol Toxicol. 1977;17:311-23. doi: 10.1146/annurev.pa.17.040177.001523. Annu Rev Pharmacol Toxicol. 1977. PMID: 17355 Review. No abstract available.
• [Beta receptor blockaders in the treatment of hypertension].

  Lohmöller G, Lydtin H. Lohmöller G, et al. Med Klin. 1976 Nov 19;71(47):2051-7. Med Klin. 1976. PMID: 12458 Review. German. No abstract available.
• [Bases of pharmacological therapy of essential hypertension].

  Scapellato L, Stornello M. Scapellato L, et al. Recenti Prog Med. 1980 Jul;69(1):72-106. Recenti Prog Med. 1980. PMID: 6107967 Review. Italian. No abstract available.